The evolution of imaging in cancer

Current state and future challenges

Luke J. Higgins, Martin Gilbert Pomper

Research output: Contribution to journalArticle

Abstract

Molecular imaging allows for the remote, noninvasive sensing and measurement of cellular and molecular processes in living subjects. Drawing upon a variety of modalities, molecular imaging provides a window into the biology of cancer from the subcellular level to the patient undergoing a new, experimental therapy. As signal transduction cascades and protein interaction networks become clarified, an increasing number of relevant targets for cancer therapy-and imaging-become available. Although conventional imaging is already critical to the management of patients with cancer, molecular imaging will provide even more relevant information, such as early detection of changes with therapy, identification of patient-specific cellular and metabolic abnormalities, and the disposition of therapeutic, gene-tagged cells throughout the body-all of which will have a considerable impact on morbidity and mortality. This overview discusses molecular imaging in oncology, providing examples from a variety of modalities, with an emphasis on emerging techniques for translational imaging.

Original languageEnglish (US)
Pages (from-to)3-15
Number of pages13
JournalSeminars in Oncology
Volume38
Issue number1
DOIs
StatePublished - Feb 2011

Fingerprint

Molecular Imaging
Neoplasms
Protein Interaction Maps
Investigational Therapies
Signal Transduction
Therapeutics
Morbidity
Mortality
Genes

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

The evolution of imaging in cancer : Current state and future challenges. / Higgins, Luke J.; Pomper, Martin Gilbert.

In: Seminars in Oncology, Vol. 38, No. 1, 02.2011, p. 3-15.

Research output: Contribution to journalArticle

@article{3ee8a03e03e84d2e83a7f88cfed929b7,
title = "The evolution of imaging in cancer: Current state and future challenges",
abstract = "Molecular imaging allows for the remote, noninvasive sensing and measurement of cellular and molecular processes in living subjects. Drawing upon a variety of modalities, molecular imaging provides a window into the biology of cancer from the subcellular level to the patient undergoing a new, experimental therapy. As signal transduction cascades and protein interaction networks become clarified, an increasing number of relevant targets for cancer therapy-and imaging-become available. Although conventional imaging is already critical to the management of patients with cancer, molecular imaging will provide even more relevant information, such as early detection of changes with therapy, identification of patient-specific cellular and metabolic abnormalities, and the disposition of therapeutic, gene-tagged cells throughout the body-all of which will have a considerable impact on morbidity and mortality. This overview discusses molecular imaging in oncology, providing examples from a variety of modalities, with an emphasis on emerging techniques for translational imaging.",
author = "Higgins, {Luke J.} and Pomper, {Martin Gilbert}",
year = "2011",
month = "2",
doi = "10.1053/j.seminoncol.2010.11.010",
language = "English (US)",
volume = "38",
pages = "3--15",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - The evolution of imaging in cancer

T2 - Current state and future challenges

AU - Higgins, Luke J.

AU - Pomper, Martin Gilbert

PY - 2011/2

Y1 - 2011/2

N2 - Molecular imaging allows for the remote, noninvasive sensing and measurement of cellular and molecular processes in living subjects. Drawing upon a variety of modalities, molecular imaging provides a window into the biology of cancer from the subcellular level to the patient undergoing a new, experimental therapy. As signal transduction cascades and protein interaction networks become clarified, an increasing number of relevant targets for cancer therapy-and imaging-become available. Although conventional imaging is already critical to the management of patients with cancer, molecular imaging will provide even more relevant information, such as early detection of changes with therapy, identification of patient-specific cellular and metabolic abnormalities, and the disposition of therapeutic, gene-tagged cells throughout the body-all of which will have a considerable impact on morbidity and mortality. This overview discusses molecular imaging in oncology, providing examples from a variety of modalities, with an emphasis on emerging techniques for translational imaging.

AB - Molecular imaging allows for the remote, noninvasive sensing and measurement of cellular and molecular processes in living subjects. Drawing upon a variety of modalities, molecular imaging provides a window into the biology of cancer from the subcellular level to the patient undergoing a new, experimental therapy. As signal transduction cascades and protein interaction networks become clarified, an increasing number of relevant targets for cancer therapy-and imaging-become available. Although conventional imaging is already critical to the management of patients with cancer, molecular imaging will provide even more relevant information, such as early detection of changes with therapy, identification of patient-specific cellular and metabolic abnormalities, and the disposition of therapeutic, gene-tagged cells throughout the body-all of which will have a considerable impact on morbidity and mortality. This overview discusses molecular imaging in oncology, providing examples from a variety of modalities, with an emphasis on emerging techniques for translational imaging.

UR - http://www.scopus.com/inward/record.url?scp=79952176166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952176166&partnerID=8YFLogxK

U2 - 10.1053/j.seminoncol.2010.11.010

DO - 10.1053/j.seminoncol.2010.11.010

M3 - Article

VL - 38

SP - 3

EP - 15

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 1

ER -